Management Board ǀ Apogenix

Apogenix develops innovative protein therapeutics for the treatment of cancer and other malignant diseases. Our lead drug candidate APG101 has demonstrated a statistically significant efficacy in a controlled phase II trial in recurrent glioblastoma.

The Perfect Corporate Board: A Handbook for Mastering the Unique Challenges of Small-Cap Companies: 9780071799546: Epstein, Adam: Books

Rapport API Management & Platform 2022 Gartner

Clinical Candidates ǀ Apogenix

Best Board Management Software 2024

Cameron, Kim S., Quinn, Robert E.: 9780470650264: Books

Diagnosing and Changing Organizational Culture: Based on the Competing Values Framework

Investors ǀ Apogenix

Stronghold Games Terraforming Mars Ares Expedition Card Game Collectors Edition, Board Games - Canada

Regulatory chromatin rewiring promotes metabolic switching during adaptation to oncogenic receptor tyrosine kinase inhibition

HERA Technology Platform ǀ Apogenix

Now in its seventh edition, Managing Innovation: Integrating Technological, Market and Organizational Change enables graduate and undergraduate

Managing Innovation: Integrating Technological, Market and Organizational Change, 7th Edition

Clinical Trials in Glioblastoma ǀ Apogenix

Apogee Change Enablement Solutions

The Handbook of Board Governance: A Comprehensive Guide for Public, Private, and Not-for-Profit Board Members: Leblanc, Richard: 9781118895504: Books